Hail, how? How could you be so wrong? What will it take $20/share? $30/share? The move on Synta hasn't even begun. Ganetespib is a 1 Billion dollar drug, totally un-partnered, which means Synta OWNS ALL THE REVENUE ON APPROVAL! Wait until that tidbit sinks in, Synta OWNS IT ALL!
THAT is a perfect example of why I stayed away, and why future visits are likely to be more infrequent. Nothing but a bunch of insane kool-aid drinking cheerleaders around here. It's a waste of time coming here and being the voice of reason for people who's hormones are flowing like a teenager getting to second base for the first time.
Synta owns it all? Good...maybe they can sell it to farmers as fertilizer, and make some of their sunk costs back.
Now that the hopium is starting to wear off, if y'all want to read the wisdom I have to impart, go back through the archives, because I've nothing new to say. I'm just sticking around to gloat.
I do like the SNTA price rise, but it is too soon to gloat as we haven't seen the NSCLC data for the phase 2b part of the Galaxy trial. SNTA management says we will see the data in July and they are very confident but we still need to see the data. Consider the time before then as akin to the pre-ASCO rise that is often seen.